Vipin Garg

Vipin Garg is from Gaithersburg, MD. Vipin is currently President, CEO and Board Director at Altimmune, Inc. (NASDAQ: ALT), located in Gaithersburg, MD. In Vipin's previous role as a President, CEO and Board Director at Neos Therapeutics, Inc., Vipin worked in Dallas/Fort Worth, TX and Blue Bell, PA until Jul 2018. Prior to joining Neos Therapeutics, Inc., Vipin was a President, CEO and Board Director at Tranzyme Pharma (NASDAQ: TZYM; Acquired by Mallinckrodt Pharmaceuticals) and held the position of President, CEO and Board Director at Research Triangle Park, NC and Sherbrooke, QC, Canada. Prior to that, Vipin was a Chief Operating Officer at Apex Bioscience, Inc. (Merged with Curacyte AG of Germany), based in Research Triangle Park, North Carolina from Jan 1994 to Jan 2000. Vipin started working as Vice President, Development at DNX Therapeutics (NASDAQ: DNXX; Acquired by Baxter International) in Princeton, New Jersey in Jan 1992.